NEW YORK (GenomeWeb) – Roche is investing CHF 450 million ($462 million) during the next three years to establish a diagnostic manufacturing facility at the Suzhou Industrial Park in Suzhou, China. The new facility is being built to meet growing demand for diagnostic tests in the country and in the Asia-Pacific region, and will focus on immunochemistry and clinical chemistry tests. The facility will employ more than 600 people in the coming years, Roche said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.